Yersinia Enterocolitica

Timothy L. Cover, Robert Aber

Research output: Contribution to journalReview article

473 Scopus citations

Abstract

YERSINIA ENTEROCOLITICA is rapidly emerging worldwide as an enteric pathogen associated with a wide spectrum of clinical and immunologic manifestations. The clinical illness caused by this pathogen ranges from self-limited enterocolitis to potentially fatal systemic infection; post-infection manifestations include erythema nodosum and reactive arthritis. The organism was first described by Schleifstein and Coleman in 1939 as “an unidentified microorganism resembling Bacterium lignieri and Pasteurella pseudotuberculosis, and pathogenic for man.”1 Isolates were variously named Bacterium enterocoliticum, P. X, P. pseudotuberculosis type b, Germe X, and P. pseudotuberculosis X, until 1964, when Frederiksen proposed the name Yersinia enterocolitica.2 In.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalNew England Journal of Medicine
Volume321
Issue number1
DOIs
StatePublished - Jul 6 1989

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this